[논문]Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 Compared to Their Susceptibilities to 11 Other Agents

Credito, Kim L.; Lin, Gengrong; Pankuch, Glenn A.; Bajaksouzian, Saralee; Jacobs, Michael R.; Appelbaum, Peter C.

doi:10.1128/aac.45.1.67-72.2001

[해외논문] Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 Compared to Their Susceptibilities to 11 Other Agents 원문보기

Antimicrobial agents and chemotherapy, v.45 no.1, 2001년, pp.67 - 72

Credito, Kim L. (<) , Lin, Gengrong (!--label omitted: 1-->) , Pankuch, Glenn A. (Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 and) , Bajaksouzian, Saralee (<) , Jacobs, Michael R. (!--label omitted: 1-->) , Appelbaum, Peter C. (Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 and)

Abstract ▼ AI-Helper

ABSTRACT The activity of the ketolide ABT-773 against Haemophilus and Moraxella was compared to those of 11 other agents. Against 210 Haemophilus influenzae strains (39.0% β-lactamase positive), microbroth dilution tests showed that azithromycin and ABT-773 had the lowest MICs (0.5 to 4.0 and 1.0 to 8.0 μg/ml, respectively), followed by clarithromycin and roxithromycin (4.0 to >32.0 μg/ml). Of the β-lactams, ceftriaxone had the lowest MICs (≤0.004 to 0.016 μg/ml), followed by cefixime and cefpodoxime (0.008 to 0.125 and ≤0.125 to 0.25 μg/ml, respectively), amoxicillin-clavulanate (0.125 to 4.0 μg/ml), and cefuroxime (0.25 to 8.0 μg/ml). Amoxicillin was only active against β-lactamase-negative strains, and cefprozil had the highest MICs of all oral cephalosporins tested (0.5 to >32.0 μg/ml). Against 50 Moraxella catarrhalis strains, all of the compounds except amoxicillin and cefprozil were active. Time-kill studies against 10 H. influenzae strains showed that ABT-773, at two times the MIC, was bactericidal against 9 of 10 strains, with 99% killing of all strains at the MIC after 24 h; at 12 h, ABT-773 gave 90% killing of all strains at two times the MIC. At 3 and 6 h, killing by ABT-773 was slower, with 99.9% killing of four strains at two times the MIC after 6 h. Similar results were found for azithromycin, with slightly slower killing by erythromycin, clarithromycin, and roxithromycin, especially at earlier times. β-Lactams were bactericidal against 8 to 10 strains at two times the MIC after 24 h, with slower killing at earlier time periods. Most compounds gave good killing of five M. catarrhalis strains, with β-lactams killing more rapidly than other drugs. ABT-773 and azithromycin gave the longest postantibiotic effects (PAEs) of the ketolide-macrolide-azalide group tested (4.4 to >8.0 h), followed by clarithromycin, erythromycin, and roxithromycin. β-Lactam PAEs were similar and shorter than those of the ketolide-macrolide-azalide group for all strains tested.

참고문헌 (23)

J. Antimicrob. Chemother. Berk S. L. 85 38 1996 10.1093/jac/38.suppl_A.85 Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. Berk S. L. Kalbfleisch J. H. the Alexander Project Collaborative Group Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. J. Antimicrob. Chemother. 38 (Suppl. A) 1996 85 96

상세보기
Brueggemann, Angela B., Doern, Gary V., Huynh, Holly K., Wingert, Elizabeth M., Rhomberg, Paul R.. In Vitro Activity of ABT-773, a New Ketolide, against Recent Clinical Isolates of Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis. Antimicrobial agents and chemotherapy, vol.44, no.2, 447-449.

상세보기
Craig, W A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.26, no.1, 1-10.

상세보기
Craig W. A. Gudmundsson S. Postantibiotic effect Antibiotics in laboratory medicine. Lorian V. 1996 265 329 The Williams and Wilkins Co. Baltimore Md
Pediatr. Infect. Dis. J. Dagan R. 95 19 2000 10.1097/00006454-200002000-00002 Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Dagan R. Johnson C. E. McLinn S. Abughali N. Feris J. Leibovitz E. Burch D. J. Jacobs M. R. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19 2000 95 104

상세보기
Dagan, Ron, Leibovitz, Eugene, Fliss, Dan M., Leiberman, Alberto, Jacobs, Michael R., Craig, William, Yagupsky, Pablo. Bacteriologic Efficacies of Oral Azithromycin and Oral Cefaclor in Treatment of Acute Otitis Media in Infants and Young Children. Antimicrobial agents and chemotherapy, vol.44, no.1, 43-50.

상세보기
Davies, Todd A., Kelly, Linda M., Hoellman, Dianne B., Ednie, Lois M., Clark, Catherine L., Bajaksouzian, Saralee, Jacobs, Michael R., Appelbaum, Peter C.. Activities and Postantibiotic Effects of Gemifloxacin Compared to Those of 11 Other Agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrobial agents and chemotherapy, vol.44, no.3, 633-639.

상세보기
Medicine (Baltimore) Fang G. D. 307 69 1990 10.1097/00005792-199009000-00004 New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Fang G. D. Fine M. Orloff J. Arisumi D. Yu V. L. Kapoor W. Grayston J. T. Wang S. P. Kohler R. Muder R. R. Yee Y. C. Rihs J. D. Vickers R. M. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 69 1990 307 316

상세보기
J. Antimicrob. Chemother. Goldstein F. W. 25 25 1990 10.1093/jac/25.suppl_A.25 Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. Goldstein F. W. Emiran M. E. Coutrot A. Acar J. F. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J. Antimicrob. Chemother. 25 (Suppl. A) 1990 25 28
Pediatr. Infect. Dis. Hoberman A. 955 10 1996 10.1097/00006454-199610000-00034 Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae. Hoberman A. Paradise J. L. Block S. Burch D. J. Jacobs M. R. Balanescu M. I. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae. Pediatr. Infect. Dis. 10 1996 955 962

상세보기
Jacobs, Michael R., Bajaksouzian, Saralee, Zilles, Anne, Lin, Gengrong, Pankuch, Glenn A., Appelbaum, Peter C.. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study. Antimicrobial agents and chemotherapy, vol.43, no.8, 1901-1908.

상세보기
J. Antimicrob. Chemother. Maskell J. P. 19 25 1990 10.1093/jac/25.suppl_A.19 Comparative in-vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. Maskell J. P. Sefton A. M. Williams J. D. Comparative in-vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. J. Antimicrob. Chemother. 25 (Suppl. A) 1990 19 24
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS publication no. M7-A4. 1997 National Committee for Clinical Laboratory Standards Wayne Pa
Needham, C A. Haemophilus influenzae: antibiotic susceptibility. Clinical microbiology reviews, vol.1, no.2, 218-227.

상세보기
J. Antimicrob. Chemother. Neu H. C. 1 27 1991 10.1093/jac/27.suppl_A.1 The development of macrolides: clarithromycin in perspective. Neu H. C. The development of macrolides: clarithromycin in perspective. J. Antimicrob. Chemother. 27 (Suppl. A) 1991 1 9
J. Antimicrob. Chemother. Olsson-Liljequist B. 11 27 1991 10.1093/jac/27.suppl_A.11 In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite against Haemophilus influenzae. Olsson-Liljequist B. Hoffman B.-M. In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite against Haemophilus influenzae. J. Antimicrob. Chemother. 27 (Suppl. A) 1991 11 17
Pankuch, Glenn A., Hoellman, Dianne B., Lin, Gengrong, Bajaksouzian, Saralee, Jacobs, Michael R., Appelbaum, Peter C.. Activity of HMR 3647 Compared to Those of Five Agents against Haemophilus influenzae and Moraxella catarrhalis by MIC Determination and Time-Kill Assay. Antimicrobial agents and chemotherapy, vol.42, no.11, 3032-3034.

상세보기
Pankuch, G A, Jacobs, M R, Appelbaum, P C. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial agents and chemotherapy, vol.38, no.9, 2065-2072.

상세보기
Pankuch, G A, Lichtenberger, C, Jacobs, M R, Appelbaum, P C. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrobial agents and chemotherapy, vol.40, no.7, 1653-1656.

상세보기
Pankuch, G. A., Visalli, M. A., Jacobs, M. R., Appelbaum, P. C.. Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other Agents. Antimicrobial agents and chemotherapy, vol.42, no.3, 624-630.

상세보기
J. Antimicrob. Chemother. Vallee E. 31 27 1991 10.1093/jac/27.suppl_A.31 Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection. Vallee E. Azoulay-Dupuis A. Swanson R. Bergogne-Berezin E. Pocidalo J.-J. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection. J. Antimicrob. Chemother. 27 (Suppl. A) 1991 31 41
Yeo, S. F., Akalin, E., Arikan, S., Auckenthaler, R., Bergan, T., Dornbusch, K., Howard, A. J., Hryniewicz, W., Jones, R. N., Koupari, G.. Susceptibility testing of Haemophilus influenzae - an international collaborative study in quality assessment. The Journal of antimicrobial chemotherapy, vol.38, no.3, 363-386.

상세보기
Clin. Ther. Zeckel M. L. 214 14 1992 Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. Zeckel M. L. Jacobson K. D. Guerra F. J. Therasse D. G. Farlow D. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Ther. 14 1992 214 229

상세보기

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

원문 보기

AccessON 원문보기

원문 URL 링크

DOI : 10.1128/AAC.45.1.67-72.2001 [무료]
PubMed Central : 저널 > 논문 [무료]
American Society for Microbiology : 저널> 권호 > 논문 [무료]
AccessON : 저널

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내

내보내기 메뉴

내보내기 구분

파일저장
인쇄
메일전송

구성항목

기본정보
상세정보

관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관

저장형식

Text(ASCII format)
Excel format
RefWorks Direct Export
RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley

메일정보

받는사람 (필수): @
보내는사람 (선택): @
제목
내용: KISTI 검색결과 이메일 서비스

안내

총 건의 자료가 검색되었습니다.

다운받으실 자료의 인덱스를 입력하세요. (1-10,000)

검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다.

데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요)

다운로드 파일은 UTF-8 형태로 저장됩니다.
파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오.

Text(ASCII format)
Excel format

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

연합인증